Amer Sports stock coverage resumed at Equalweight by Morgan Stanley

Morgan Stanley resumed coverage of Amer Sports with an Equalweight rating and $31 price target, versus a $27.77 share price, arguing that its growth and profitability are already largely reflected in consensus forecasts and valuation. The bank projects Q3 EBITDA of $420 million versus $412 million consensus and EPS of $0.34 versus $0.33, but sees only low-single-digit EBITDA upside and limited scope for multiple expansion at roughly 9x 2027E EV/EBITDA. Amer Sports previously posted Q2 adjusted EPS of $0.22 and $1.63 billion in revenue, with sales up 32% year over year, and raised full-year revenue-growth guidance to about 24%.

Analysis

The investable question is not whether the next quarter clears consensus by a cent or two, but whether AS can convert brand momentum into durable post-launch sell-through without stepping up promotional activity. With forward expectations already assuming segment-level growth above management’s prior framework, a modest earnings beat is more likely to stabilize the shares than drive a sustained rerating; the market needs evidence that gross-margin resilience survives a slower growth cadence.

Arc’teryx’s China exposure and Salomon’s performance/outdoor category create asymmetric downside if discretionary demand weakens or channel inventories rise: premium brands can protect price initially, but wholesale order cuts appear with a lag and can pressure utilization and marketing efficiency over the following two to three quarters. Conversely, verified full-price sell-through would strengthen AS’s negotiating leverage with wholesale partners and widen the gap versus more promotional athletic-apparel peers such as NKE and LULU.

The contrarian setup is that the low share price and wide sell-side target dispersion may have shifted the near-term burden from "beat" to "avoid a deceleration scare." A small upside print alone should not be chased, because the key falsifier is a reduction in full-year growth guidance, weaker China commentary, or gross-margin performance that fails to benefit from operating leverage. The next 1-3 month catalyst is earnings and channel data; the 6-18 month thesis depends on whether Arc’teryx and Salomon can scale without sacrificing premium positioning.

Key Decisions for Investors

• Treat AS as a tactical, not core, long into the next earnings release: initiate only after a sustained recovery above $28.50, target $33.00, and exit on a close below $26.50. This offers roughly 2:1 upside/downside and requires confirmation that the 52-week-low area is becoming support rather than a breakdown level.
• Add to AS only if management reiterates or raises full-year growth while demonstrating gross-margin expansion and continued positive China sell-through. A revenue beat without margin leverage or with increased promotional/marketing spending is not sufficient for a larger position.
• Do not establish a relative-value short against ONON, DECK, NKE, or LULU before obtaining current peer EV/EBITDA multiples, regional revenue exposure, and inventory data; the proposed long-AS/short-premium-consumer pair is a watch item rather than a recommendation because category demand sensitivity differs materially.
• Set a risk alert for any guidance reset or commentary indicating wholesale inventory accumulation in Outdoor or Ball & Racquet. Such evidence would undermine the durability thesis and could justify avoiding AS despite an apparently inexpensive longer-dated valuation.